Solusi lisan Femalto 30ml CPC1HN ditambah karo wesi organik cair

Bentuk sediaan Solusi
Spesifikasi kothak
Komposisi Besi (III) Hidroksid Polimaltosa

Komposisi

Thành phần cho 1ml

Informasi komposisi	Isi
Besi (III) Hidroksid Polimaltosa	50 mg

Migunakake

Indikasi

Solusi oral femalto digunakake kanggo perawatan kekurangan zat besi tanpa anemia lan kekurangan zat besi sing diiringi anemia kanggo pasien sing beresiko kayata:

Wong meteng.

Wong sing nyusoni. B03ab05

Mekanisme: Wesi minangka bahan kanggo mbentuk hemoglobin.

wesi sing diserep utamane disimpen ing ati, sing ana hubungane karo feritin. Banjur digabungake ing sumsum balung menyang hemoglobin.

farmakokinetik

penyerapan, distribusi

Rasio panyerepan utawa wesi digandhengake karo hemoglobin sing proporsi kuwalik karo dosis. Jumlah wesi sing diserap gumantung saka tingkat kekurangan zat besi (sing luwih dhuwur kekurangan zat besi luwih dhuwur kemampuan kanggo nyerep). Nggunakake obat-obatan ing perawatan, tingkat panyerepan kira-kira 10%. Obat kasebut diserep ing usus cilik utamane ing kelenjar getah bening lan duodenum.

Metabolisme lan eliminasi

wesi ora nyerep ekskresi liwat feces.

Sadurunge njupuk Solusi lisan Femalto 30ml CPC1HN ditambah karo wesi organik cair

How to use can mix femalto with fruit juice, vegetable juice or bottled water. Can be used once a day or many times/day. 1 ml corresponds to 14 drops. Dosage Dosage and treatment time depend on the level of iron deficiency: Object iron deficiency with anemia iron deficiency without anemia (ml/drops) (7-14 drops) 15 - 25 0.5 (7 drops) (14 - 28 drops) 25 - 50 0.5 - 1 (7 - 14 drops) (28 - 84 drops) 50 - 100 1 - 2 (14 - 28 drops) In case of significant signs of iron deficiency, it is necessary to treat for about 3-5 months until the value of hemoglobin returns to normal. After that, it is necessary to continue treating for a few weeks with indications for potential iron deficiency to supplement the amount of iron reserves. The hidden iron deficiency treatment time is not accompanied by anemia lasting 1-2 months. Specific dose depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do do when using overdose? The comparative studies between iron (II) sulfate and iron (III) Hydroxyd polymaltose on the mouse also identify the LD50 of iron (II) sulfate as 350 mg/kg, but there is no disease or death in the IPC group with doses of over 1000 mg/kg. IPC's iron absorption is less, but IPC has better gastrointestinal intake, along with a higher IPC safety, which can be important to reduce the risk of iron overdose. Although IPC is safer than iron salts (II) inorganic, can still overdose but rare. Symptoms of iron overdose include fatigue, nausea, vomiting, abdominal pain, stools such as darkness, fast and weak pulse, fever, coma, convulsions and death. Need emergency immediately if iron overdose. Actively monitor for timely measures. In an emergency, call the 115 emergency center immediately or go to the nearest local health station. What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Efek sisih

Efek sing ora dikarepake diklasifikasikake adhedhasar frekuensi, kalebu: umum banget (ADR ≥ 1/10); Umum (1/100 ≤ ADR

Efek sing paling ora dikarepake ing laporan klinis yaiku ilang (23% pasien) amarga ngilangi wesi.

gangguan sistem kekebalan:

Jarang banget: reaksi alergi.

Gangguan pencernaan:

Umum banget: feces luntur.

Umum: diare, mual, gangguan pencernaan.

Kurang: gatel, ruam.

Gangguan saraf pusat:

Kurang: sirah. Watesi untu kusam kanthi matesi kontak untu karo obat nalika dijupuk.

Kanthi reaksi salabetipun cilik, mungkasi nggunakake tamba reaksi bakal mungkasi. Ing kasus sensitivitas abot, utawa reaksi alergi, perlu kanggo nindakake perawatan ndhukung (njaga hawa lan nggunakake epinefrin oksigen, nggunakake antihistaminecorticoid ...).

Pènget

Sadurunge nggunakake obat sampeyan kudu maca instruksi kasebut kanthi teliti lan deleng informasi ing ngisor iki.

Kontraindikasi

Solusi oral Femalto dikontraindikasi ing kasus ing ngisor iki:

Hipersensitifitas marang komponen obat apa wae.

Ati-ati nalika nggunakake

sodium methyl parahydroxybenzoate, sodium propyl parahydroxybenzoate bisa nyebabake reaksi hipersensitivitas, kalebu reaksi pungkasan.

Yen perawatan gagal (nambah hemoglobin kira-kira 2-3 g/dl sawise 3 minggu), sampeyan kudu nimbang maneh perawatan.

Yen pasien kudu mbaleni transfusi getih, ati-ati amarga sel getih abang bisa nambah jumlah wesi sing nyebabake kakehan wesi.

Infèksi utawa tumor bisa nyebabake anemia. Mula, perlu kanggo nambani penyakit oyod lan banjur nambahi zat besi liwat lisan lan kudu nimbang keuntungan lan risiko.

Nggunakake obat kanggo wanita ngandhut lan lactating

Produk kasebut dituduhake kanggo wanita ngandhut lan lactating ing kasus sing ana risiko anemia kurang zat besi.

Efek obat ing kemampuan nyopir, mesin operasi

ora mengaruhi.

Interaksi obat

Panliten tikus ora nuduhake yen interaksi antara wesi (III) hidroksid polimaltosa karo obat-obatan ing ngisor iki: tetrasiklin, aluminium hidroksid, asetilsalisilat, sulfasalazin, kalsium karbonat, kalsium asetat, kalsium fosfat kanthi kombinasi karo vitamin D3, bromazepam, magnesiti Aspartalin, Paracetamol Auranofin.

Semono uga, ora ana interaksi antara wesi (III) Hydroxyd polymaltose karo panganan sing ngandhut asam fitat, asam oksalat, tanin, natrium alginat, kolin lan uyah kolin, vitamin A, vitamin D3, vitamin E, lenga soya ing studi nyetak in vitro.

Bisa nggunakake wesi (III) Hydroxyd polymaltose sajrone utawa langsung sawise mangan.

Interaksi antarane wesi (III) Hydroxyd polymaltose lan tetracyclin utawa hydroxyd aluminium wis dievaluasi liwat 3 studi manungsa (cross-study, 22 pasien / riset). Ora ana penurunan sing signifikan ing tingkat penyerapan tetrasiklin. Konsentrasi tetracycline ing plasma cukup kanggo nyuda efek. Tingkat penyerapan wesi saka wesi (III) Hydroxyd polymaltose uga ora dikurangi dening aluminium hidroksid lan tetrasiklin. Mulane, wesi (III) bisa digunakake bebarengan (III) saka polymaltose hydroxyd karo tetracyclin utawa senyawa fenolik lan uyah aluminium.

Ora mung dituduhake kanggo nggunakake injeksi lan femalto tambahan ing wektu sing padha amarga panyerepan wesi lisan sing bisa nyandhet lan mung digunakake nyuntikaken kanthi lisan ora cocog.

Panyimpenan

Simpen ing suhu ora ngluwihi 30 ° C ing kemasan asli, aja nganti lembab lan aja nganti cahya.

Obat liyane

Disclaimer

Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.

Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.